Meridian bioscience stock.

8 Feb 2022 ... Special Sign on Equity Award: We are pleased to offer you 7,500 RSUs, and 5,000 Options upon hire, pursuant to the Meridian Stock Incentive Plan ...Feb 1, 2023. In vitro diagnostics company SD Biosensor and private equity investment firm SJL Partners announced on Tuesday that they have completed their acquisition of Cincinnati-based life science company Meridian Bioscience. The acquisition was agreed upon in July 2022 as an all-cash transaction valued at approximately $1.53 billion.Looking at the universe of stocks we cover at Dividend Channel, on 8/1/13, Meridian Bioscience Inc. (NASD: VIVO) will trade ex-dividend, for its quarterly dividend of $0.19, payable on 8/15/13. About After Hours Quotes. Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. Meridian Bioscience Inc. Common Stock (VIVO) After ...Track Meridian Bioscience Inc. (VIVO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Legal Name Meridian Bioscience, Inc. Stock Symbol NASDAQ:VIVO. Company Type For Profit. Phone Number 5132725421. Meridian Bioscience is an integrated life science company. The Company is engaged in developing, manufacturing, selling, and distributing clinical diagnostic test kits, for certain gastrointestinal, viral, respiratory, and parasitic ...3 juil. 2023 ... ... Meridian Bioscience Inc. by a consortium led by SD Biosensor Inc. and ... Investors are allowed to exchange the bonds for shares of Columbus ...Meridian’s stock soared 79% during that fiscal year. Newtown-based Meridian, founded in 1977, is Greater Cincinnati’s 16th-largest public company, according to Courier research. It reported ...

Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, …

CINCINNATI, Dec. 12, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO ), a leading global provider of diagnostic testing solutions and life science raw materials, announced that it has ...About Meridian Bioscience, Inc. Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products.Jan 30, 2023 · Meridian Bioscience, Inc. announced that it expects to receive KRW 258.225164381 billion in funding. Jun. 11. CI. Meridian Bioscience, Inc. Announces FDA Clearance for Innovative Curian® Shiga Toxin Assay. Shareholders of Meridian, as recorded in our stock register on December 8, 2003, may vote at the meeting. As of that date, Meridian had 14,826,046 shares of ...

Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 33.33% and 2.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Dec 31, 2022 · Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies ...

The illumipro-10™ is an automated isothermal amplification and detection system for use with Meridian Bioscience, Inc. ... All items in stock and available ...Mr. Phillips VIVO stock SEC Form 4 insiders trading. David has made over 8 trades of the Meridian Bioscience stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 7,500 units of VIVO stock worth $139,050 on 12 January 2022.. The largest trade he's ever made was buying 10,000 units of Meridian …About Meridian Bioscience, Inc. Meridian is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic products.Meridian Bioscience, Inc. (NASDAQ:VIVO) announced its quarterly earnings results on Friday, November, 12th. The company reported $0.24 EPS for the quarter, ...

Under the terms of the agreement, Meridian shareholders will receive $34.00 per share in cash, which represents a premium of approximately 32% over Meridian's closing stock price on the day before ...Jan 31, 2023 · The estimated Net Worth of John P. Kenny is at least $17.5 Million dollars as of 24 June 2022. Mr Kenny owns over 74,996 units of Meridian Bioscience stock worth over $11,093,515 and over the last 6 years he sold VIVO stock worth over $4,939,280. In addition, he makes $1,508,705 as Pres and CEO & Director at Meridian Bioscience.Meridian Bioscience (NASDAQ:VIVO) is a fully-integrated developer of diagnostic systems through its diagnostics segment, ... That means Meridian is a highly valued stock right now, and the prices ...Meridian Bioscience Announces Preliminary Results for Fiscal 2022 Third Quarter 2022-07-07 - 2 views Form of Indemnification Agreement 2022-07-07 - 1 view Agreement and Plan of Merger, dated as of July 7, 2022, by and among Meridian Bioscience, Inc., SD Biosensor, Inc., Columbus Holding Company, and Madeira Acquisition Corp.* 2022-07 …Dec 1, 2023 · Historical price to free cash flow ratio values for Meridian Bioscience Inc. (VIVO) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide .Under the terms of the agreement, Meridian shareholders will receive $34.00 per share in cash, which represents a premium of approximately 32% over Meridian's closing stock price on the day before ...Dec 12, 2022 · CINCINNATI, Dec. 12, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO ), a leading global provider of diagnostic testing solutions and life science raw materials, announced that it has ...

Meridian's website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected]

Meridian's website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected]. Phillips VIVO stock SEC Form 4 insiders trading. David has made over 8 trades of the Meridian Bioscience stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 7,500 units of VIVO stock worth $139,050 on 12 January 2022.. The largest trade he's ever made was buying 10,000 units of Meridian …Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, …Products. Diagnostic assays that deliver the best patient outcomes rely on high-quality reagents. Meridian offers diagnostic manufacturers the complete solution with over 3,000 antigens and antibodies covering more than 500 disease targets and an extensive range of specialty qPCR master mixes and molecular enzymes manufactured under ISO13485 ...Mar 24, 2016 · Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ... Jan 30, 2023 · Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ... From a 100x stock, you need to add 0.5 µL to a 50 µL reaction. Meridian also offers more diluted mixes of 40mM total (10mM each), which is a 50x stock solution and 10 mM total (2.5 mM each) 10x working stock.The estimated total pay for a Account Executive at Meridian Bioscience is $167,272 per year. ... Additional pay could include bonus, stock, commission, profit sharing or tips. The "Most Likely Range" represents values that exist within the 25th and 75th percentile of all pay data available for this role.Nov 12, 2021 · Meridian's website address is www.meridianbioscience.com. Contact: Charlie Wood Vice President – Investor Relations Meridian Bioscience, Inc. Phone: +1 513.271.3700 Email: [email protected] Other Medical Equipment, Supplies & Distribution. Meridian Bioscience, Inc. (0K0K.LON) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock …

Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...

Jan 31, 2023 · The estimated Net Worth of Catherine Sazdanoff is at least $365 Thousand dollars as of 29 April 2016. Ms. Sazdanoff owns over 7,700 units of Meridian Bioscience stock worth over $261,569 and over the last 8 years she sold VIVO stock worth over $0. In addition, she makes $103,333 as Independent Director at Meridian Bioscience.

Marviette Johnson VIVO stock SEC Form 4 insiders trading. Marviette has made over 1 trades of the Meridian Bioscience stock since 2015, according to the Form 4 filled with the SEC. Most recently Marviette sold 1,917 units of VIVO stock worth $38,167 on 2 March 2015.. The largest trade Marviette's ever made was selling 1,917 units of …Find Salaries by Job Title at Meridian Bioscience. 132 Salaries (for 79 job titles) • Updated Oct 29, 2023. How much do Meridian Bioscience employees make? Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips.Jan 31, 2023 · The estimated Net Worth of Catherine Sazdanoff is at least 365 千$ dollars as of 29 April 2016. Ms. Sazdanoff owns over 7,700 units of Meridian Bioscience stock worth over 261,569$ and over the last 8 years she sold VIVO stock worth over 0$. In addition, she makes 103,333$ as Independent Director at Meridian Bioscience.Get the latest stock quote, charts, news and analysis for Meridian Bioscience, Inc. (VIVO), a medical equipment company that develops diagnostic tests for various conditions. See the company's performance, earnings, acquisitions, acquisitions, and more on MarketScreener. Dec 13, 2022 · Summary. Meridian Biosciences released an update saying it set the closing date for its merger on Jan. 31. The stated reason is that the acquiring parties wanted some extra time to get the financing. Mr. McIlwraith VIVO stock SEC Form 4 insiders trading. John has made over 6 trades of the Meridian Bioscience stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of VIVO stock worth $37,950 on 25 February 2020.. The largest trade he's ever made was buying 5,000 units of Meridian Bioscience …Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 33.33% and 2.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock? 7 juil. 2022 ... Meridian shareholders will receive $34 per share in cash, a 1.3% premium to the stock's closing price on Wednesday, under the deal. The ...From a 100x stock, you need to add 0.5 µL to a 50 µL reaction. Meridian also offers more diluted mixes of 40mM total (10mM each), which is a 50x stock solution and 10 mM total (2.5 mM each) 10x working stock.Should You Buy or Sell Meridian Bioscience Stock? Get The Latest VIVO Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.Dec 19, 2022 · The estimated Net Worth of Bryan T Baldasare is at least $2.96 Million dollars as of 8 February 2021. Mr. Baldasare owns over 6,254 units of Meridian Bioscience stock worth over $1,906,668 and over the last 4 years he sold VIVO stock worth over $566,813. In addition, he makes $490,759 as Chief Financial Officer, Senior Vice …

Meridian Bioscience, Inc. is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized ...Get the latest stock quote, charts, news and analysis for Meridian Bioscience, Inc. (VIVO), a medical equipment company that develops diagnostic tests for various conditions. See the company's performance, earnings, acquisitions, acquisitions, and more on MarketScreener. 8 juil. 2022 ... ... stock price prior to the offer. The all-cash transaction is expected to close in Q4, leaving SDB with a 60% stake and SJL with the remaining ...Instagram:https://instagram. property management average feesfidelity trading dashboardis it better to invest in stocks or bondsoutdoorzy EX-99.1 Exhibit 99.1 For Immediate Release MERIDIAN BIOSCIENCE REPORTS RECORD SETTING FIRST QUARTER FISCAL 2021 OPERATING RESULTS AND RAISES FULL YEAR FISCAL 2021 GUIDANCE CINCINNATI, OHIO February 5, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial … home builders etfsv p g 8 Feb 2022 ... Special Sign on Equity Award: We are pleased to offer you 7,500 RSUs, and 5,000 Options upon hire, pursuant to the Meridian Stock Incentive Plan ...Meridian Bioscience, Inc. (NASDAQ:VIVO) announced its quarterly earnings results on Friday, November, 12th. The company reported $0.24 EPS for the quarter, ... gaining stocks today ... Meridian Bioscience, Inc. Meridian is a fully ... Meridian's shares are traded on the NASDAQ Global Select Market, symbol VIVO.About After Hours Quotes. Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. Meridian Bioscience Inc. Common Stock (VIVO) After ...